Terms: = Endocrine gland cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Treatment
60 results:
1. Biomarker Testing Journey Among Patients with Advanced Solid Tumors and treatment Patterns by Homologous Recombination Repair Status: A Clinico-Genomic Database Study.
Shao C; Ren Y; Zhou H; Lee LC; Chen C; Dettman EJ; Cristescu R; Gozman A; Jin F; Zhou W
Adv Ther; 2024 Feb; 41(2):759-776. PubMed ID: 38169059
[TBL] [Abstract] [Full Text] [Related]
2. Anticancer Evaluation of Methoxy Poly(Ethylene Glycol)-
Shin YB; Choi JY; Shin DH; Lee JW
Int J Nanomedicine; 2023; 18():2209-2223. PubMed ID: 37152471
[TBL] [Abstract] [Full Text] [Related]
3. Surgical treatment for pancreatic cystic lesions-implications from the multi-center and prospective German StuDoQ|Pancreas registry.
Henn J; Wyzlic PK; Esposito I; Semaan A; Branchi V; Klinger C; Buhr HJ; Wellner UF; Keck T; Lingohr P; Glowka TR; Manekeller S; Kalff JC; Matthaei H;
Langenbecks Arch Surg; 2023 Jan; 408(1):28. PubMed ID: 36640188
[TBL] [Abstract] [Full Text] [Related]
4. PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated vegfr3 dephosphorylation.
Chang TM; Chu PY; Lin HY; Huang KW; Hung WC; Shan YS; Chen LT; Tsai HJ
J Biomed Sci; 2022 Nov; 29(1):92. PubMed ID: 36336681
[TBL] [Abstract] [Full Text] [Related]
5. Development, Characterization, and In Vitro Evaluation of Cytotoxic Activity of Rutin Loaded pcl-PEG Nanoparticles Against Skov3 Ovarian cancer Cell.
Firouzai-Amandi A; Tarahomi M; Rahmani Youshanlouie H; Mosaddeghi Heris R; Jafari-Gharabaghlou D; Zarghami N; Dadashpour M
Asian Pac J Cancer Prev; 2022 Jun; 23(6):1951-1957. PubMed ID: 35763636
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of Society Guidelines for the Management and Surveillance of Pancreatic Cysts: A Review.
Aziz H; Acher AW; Krishna SG; Cloyd JM; Pawlik TM
JAMA Surg; 2022 Aug; 157(8):723-730. PubMed ID: 35731507
[TBL] [Abstract] [Full Text] [Related]
7. The role of intraperitoneal chemotherapy in the surgical management of pancreatic ductal adenocarcinoma: a systematic review.
Brind'Amour A; Webb M; Parapini M; Sidéris L; Segedi M; Chung SW; Chartier-Plante S; Dubé P; Scudamore CH; Kim PTW
Clin Exp Metastasis; 2021 Apr; 38(2):187-196. PubMed ID: 33486670
[TBL] [Abstract] [Full Text] [Related]
8. Enhanced targeting of 3D pancreatic cancer spheroids by aptamer-conjugated polymeric micelles with deep tumor penetration.
Tian L; Pei R; Zhong L; Ji Y; Zhou D; Zhou S
Eur J Pharmacol; 2021 Mar; 894():173814. PubMed ID: 33352182
[TBL] [Abstract] [Full Text] [Related]
9. Kinome Array Profiling of Patient-Derived Pancreatic Ductal Adenocarcinoma Identifies Differentially Active Protein Tyrosine Kinases.
Creeden JF; Alganem K; Imami AS; Brunicardi FC; Liu SH; Shukla R; Tomar T; Naji F; McCullumsmith RE
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33213062
[TBL] [Abstract] [Full Text] [Related]
10. Diagnostic performance of current guidelines and postoperative outcome following surgical treatment of cystic pancreatic lesions - a 10-year single center experience.
Kovacevic B; Hansen MC; Kristensen TS; Karstensen JG; Klausen P; Storkholm J; Hansen CP; Vilmann P
Scand J Gastroenterol; 2020 Dec; 55(12):1447-1453. PubMed ID: 33147090
[TBL] [Abstract] [Full Text] [Related]
11. Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian cancer: a Proof-of-Concept Phase II Study.
Lampert EJ; Zimmer A; Padget M; Cimino-Mathews A; Nair JR; Liu Y; Swisher EM; Hodge JW; Nixon AB; Nichols E; Bagheri MH; Levy E; Radke MR; Lipkowitz S; Annunziata CM; Taube JM; Steinberg SM; Lee JM
Clin Cancer Res; 2020 Aug; 26(16):4268-4279. PubMed ID: 32398324
[TBL] [Abstract] [Full Text] [Related]
12. Improving the Anti-Ovarian cancer Activity of Docetaxel by Self-Assemble Micelles and Thermosensitive Hydrogel Drug Delivery System.
Xu G; Zhu C; Li B; Wang T; Wan J; Zhang Y; Huang J; Yang D; Shen Y
J Biomed Nanotechnol; 2020 Jan; 16(1):40-53. PubMed ID: 31996284
[TBL] [Abstract] [Full Text] [Related]
13. Dendritic Polyglycerol-Derived Nano-Architectures as Delivery Platforms of Gemcitabine for Pancreatic cancer.
Ray P; Ferraro M; Haag R; Quadir M
Macromol Biosci; 2019 Jul; 19(7):e1900073. PubMed ID: 31183964
[TBL] [Abstract] [Full Text] [Related]
14. Timing and Clinical Features of Spontaneous Decrease in Size of Small Pancreatic Cystic Lesions without High-Risk Stigmata.
Lee HW; Lee SK; Jun JH; Song TJ; Park DH; Lee SS; Seo DW; Kim MH
Gut Liver; 2020 Mar; 14(2):248-256. PubMed ID: 31060116
[TBL] [Abstract] [Full Text] [Related]
15. Peptide P11 suppresses the growth of human thyroid carcinoma by inhibiting the PI3K/AKT/mTOR signaling pathway.
Wu D; Tian W; Li J; Zhang Q; Wang H; Zhang L; Xie Z; Ji A; Li Y
Mol Biol Rep; 2019 Jun; 46(3):2665-2678. PubMed ID: 31028568
[TBL] [Abstract] [Full Text] [Related]
16. Development, characterization and biological in vitro assays of paclitaxel-loaded pcl polymeric nanoparticles.
Abriata JP; Turatti RC; Luiz MT; Raspantini GL; Tofani LB; do Amaral RLF; Swiech K; Marcato PD; Marchetti JM
Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():347-355. PubMed ID: 30606542
[TBL] [Abstract] [Full Text] [Related]
17. Integrin β1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110β signaling.
Yang D; Tang Y; Fu H; Xu J; Hu Z; Zhang Y; Cai Q
Biochem Biophys Res Commun; 2018 Oct; 505(1):215-221. PubMed ID: 30243721
[TBL] [Abstract] [Full Text] [Related]
18. Self-Assembled Honokiol-Loaded Microbubbles in the treatment of Ovarian cancer by Ultrasound Irradiation.
Wu Q; Zhang M; Luo H; Yi T
J Biomed Nanotechnol; 2018 Oct; 14(10):1796-1805. PubMed ID: 30041725
[TBL] [Abstract] [Full Text] [Related]
19. treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT).
Wirth LJ; Tahara M; Robinson B; Francis S; Brose MS; Habra MA; Newbold K; Kiyota N; Dutcus CE; Mathias E; Guo M; Sherman SI; Schlumberger M
Cancer; 2018 Jun; 124(11):2365-2372. PubMed ID: 29656442
[TBL] [Abstract] [Full Text] [Related]
20. Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo.
Ferrari SM; Bocci G; Di Desidero T; Elia G; Ruffilli I; Ragusa F; Orlandi P; Paparo SR; Patrizio A; Piaggi S; La Motta C; Ulisse S; Baldini E; Materazzi G; Miccoli P; Antonelli A; Fallahi P
Oncol Rep; 2018 May; 39(5):2225-2234. PubMed ID: 29517103
[TBL] [Abstract] [Full Text] [Related]
[Next]
